In a bid to save both time and money, some of the industry’s biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the “open-source” manual that gave the world Linux software.If it takes off, the approach could break the mold of current drug research and speed the development of tomorrow’s life-saving medicines for diseases from cancer to autism.
